Constitutive expression of the cyclin-dependent kinase inhibitor p21 is transcriptionally regulated by the tumor suppressor protein p53

被引:56
|
作者
Tang, H
Zhao, K
Pizzolato, JF
Fonarev, M
Langer, JC
Manfredi, JJ
机构
[1] CUNY Mt Sinai Sch Med, Derald H Ruttenberg Canc Ctr, New York, NY 10029 USA
[2] CUNY Mt Sinai Sch Med, Brookdale Ctr Mol & Dev Biol, New York, NY 10029 USA
关键词
D O I
10.1074/jbc.273.44.29156
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The tumor suppressor protein p53 has been implicated in the response of cells to DNA damage. Studies to date have demonstrated a role for p53 in the transcriptional activation of target genes in the cellular response to DNA damage that results in either growth arrest or apoptosis, In contrast, here is demonstrated a role for p53 in regulating the basal level of expression of the cyclin-dependent kinase inhibitor p21 in the absence of treatment with DNA-damasng agents. Wild-type p53-expressing MCF10F cells had detectable levels of p21 mRNA and protein, whereas the p53-negative Saos-2 cells did not. Saos-2 cells were infected with recombinant retrovirus to establish a proliferating pool of cells with a comparable constitutive level of expression of wild-type p53 protein to that seen in untreated MCF10F cells. Restoration of wild-type but not mutant p53 expression recovered a basal level of expression of p21 in these cells. Constitutive expression of luciferase reporter constructs containing the p21 promoter was inhibited by co-transfection with the human MDM2 protein or a dominant-negative p53 protein and was dependent on the presence of p53 response elements in the reporter constructs. Furthermore, p53 in nuclear extracts of untreated cells was capable of binding to DNA in a sequence-specific manner. These results implicate a role for p53 in regulating constitutive levels of expression of p21 and demonstrate that the p53 protein is capable of sequence-specific DNA binding and transcriptional activation in untreated, proliferating cells.
引用
收藏
页码:29156 / 29163
页数:8
相关论文
共 50 条
  • [1] CELL-CYCLE EXPRESSION AND P53 REGULATION OF THE CYCLIN-DEPENDENT KINASE INHIBITOR P21
    LI, Y
    JENKINS, CW
    NICHOLS, MA
    XIONG, Y
    [J]. ONCOGENE, 1994, 9 (08) : 2261 - 2268
  • [2] Direct interaction of p21 cyclin-dependent kinase inhibitor with the retinoblastoma tumor suppressor protein
    Nakanishi, M
    Kaneko, Y
    Matsushime, H
    Ikeda, K
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 263 (01) : 35 - 40
  • [3] Expression of cyclin-dependent kinase inhibitor p21(WAF1) and p53 tumour suppressor gene in laryngeal cancer
    Jeannon, JP
    Soames, J
    Lunec, J
    Awwad, S
    Ashton, V
    Wilson, JA
    [J]. CLINICAL OTOLARYNGOLOGY, 2000, 25 (01): : 23 - 27
  • [4] Oncosuppressor protein p53 and cyclin-dependent kinase inhibitor p21 regulate interstitial cystitis associated gene expression
    Keay, Susan
    Nallar, Shreeram C.
    Gade, Padmaja
    Zhang, Chen-Ou
    Kalvakolanu, Dhan V.
    [J]. CYTOKINE, 2018, 110 : 110 - 115
  • [5] Expression of cyclin-dependent kinase inhibitor p21 in human liver
    Crary, GS
    Albrecht, JH
    [J]. HEPATOLOGY, 1998, 28 (03) : 738 - 743
  • [6] P53-INDEPENDENT EXPRESSION OF THE CYCLIN-DEPENDENT KINASE INHIBITOR P21 IN PANCREATIC-CARCINOMA
    DIGIUSEPPE, JA
    REDSTON, MS
    YEO, CJ
    KERN, SE
    HRUBAN, RH
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1995, 147 (04): : 884 - 888
  • [7] Expression of cyclin-dependent kinase inhibitor p21(WAFI) and p53 tumour suppressor gene in laryngeal cancer (vol 25, pg 23, 2000)
    Jeannon, JP
    Soames, J
    Lunec, J
    Awwaad, S
    Ashton, V
    Wilson, JA
    [J]. CLINICAL OTOLARYNGOLOGY, 2000, 25 (05): : 431 - 431
  • [8] Purification and crystallization of cyclin-dependent kinase inhibitor p21
    Mayrose, DR
    Nichols, MA
    Yue, XO
    Ke, HM
    [J]. PROTEIN SCIENCE, 1996, 5 (09) : 1928 - 1930
  • [9] The role of the cyclin-dependent kinase inhibitor p21 in apoptosis
    Gartel, AL
    Tyner, AL
    [J]. MOLECULAR CANCER THERAPEUTICS, 2002, 1 (08) : 639 - 649
  • [10] Cyclin-dependent kinase inhibitor p21 in endometrial carcinoma
    Backe, J
    Caffier, H
    Dietl, J
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1997, 177 (01) : 243 - 243